C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
195/1.15
C12N 15/00 (2006.01) C07H 21/04 (2006.01) C12N 15/76 (2006.01)
Patent
CA 1186253
ABSTRACT OF THE DISCLOSURE A composite plasmid selected from the group consisting of plasmid pMNl having a molecular weight of 10.0 megadaltons, plasmid pMN2 having a molecular weight of 7.6 megadaltons and plasmid pMNl' and pMN2' both having a molecular weight of 11.3 megadaltons. The composite plasmid is formed by inserting plasmid pSLl obtained from Streptomyces lavendulae into plasmid pCRl obtained from Escherichia coli and has a kanamycin resistant genetic marker and the following digestion characteristics to restriction enzymes: (i) pMNl and pMN2 have one cleavage site to each of the restriction enzymes EcoRI and SalI, and (ii) pMNl' and pMN2' have two cleavage sites to each of the restriction enzymes EcoRI and SalI.
403649
Nakano Michiko
Ogawara Hiroshi
Johnson Douglas S. Q.c.
Ogawara Hiroshi
Yamanouchi Pharmaceutical Co. Ltd.
LandOfFree
Composite plasmids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composite plasmids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composite plasmids will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1231478